Brainsway Ltd
BWAY
View Detailed Chart
15.960USD
-0.100-0.62%
Close 09/18, 16:00（ET）Quotes delayed by 15 min
603.12MMarket Cap
112.86P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-0.62%
5 Days
+1.66%
1 Month
+7.47%
6 Months
+56.78%
Year to Date
+69.25%
1 Year
+90.00%
View Detailed Chart
TradingKey Stock Score
Currency: USD Updated: 2025-09-18Key Insights
The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a weak stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
2
analysts
Buy
Current Rating
18.000
Target Price
+12.08%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Company Highlights
StrengthsRisks
Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 50.92% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 41.02M.
Turnaround to Profit
The company's performance has turned profitable, with the latest annual net income of USD 2.92M.%!(EXTRA int=2)
Overvalued
The company’s latest PE is 110.33, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 7.33M shares, increasing 7.53% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 283.86K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of -0.10.
News
More news coming soon, stay tuned...
Financial Indicators
EPS
No Data
Total revenue
No Data
Company
Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.
Ticker SymbolBWAY
CompanyBrainsway Ltd
CEOMr. Hadar Levy
Websitehttps://www.brainsway.com/
Related Instruments
+1.79%
+0.50%
-0.27%
+1.21%
+1.64%
-0.86%
+0.58%
+0.71%
-3.43%
+1.25%
+0.89%
+2.14%
+0.10%
+2.78%
+2.44%
+3.61%
+1.08%
+1.33%
+1.42%
+3.52%
